MagDI Canada Study
NCT: NCT06467955 · ACTIVE_NOT_RECRUITING
Brief Summary
The objective of the MagDI Canada study is to evaluate the performance and safety of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion as one example of a small bowel clinical procedure requiring a side-to-side anastomosis. The secondary objective includes initial efficacy of the duodeno-ileal diversion using the MagDI System.
Frequently Asked Questions
What is MagDI Canada Study?
MagDI Canada Study is a clinical trial registered under NCT06467955. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06467955?
The current status of NCT06467955 (MagDI Canada Study) is: ACTIVE_NOT_RECRUITING.
When did MagDI Canada Study start?
MagDI Canada Study started on 2024-05-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.